Fabtech Technologies IPO Sees Tepid Demand on Day 1
Fabtech Technologies' ₹230-crore IPO opened with lackluster demand, subscribing just 7% in the first hour. The engineering solutions provider for pharma and healthcare set a price band of ₹181-191 per share, offering 1.2 crore equity shares.
Non-institutional investors showed modest interest at 0.08x subscription, while retail participation reached 0.17x. Qualified institutional buyers remained absent from the bidding. The offering closes October 1, 2025.
Reliance Securities offered cautious optimism, citing Fabtech's asset-light model and presence in emerging markets as potential growth drivers. However, concerns linger about execution risks in an increasingly competitive pharmaceutical capital expenditure landscape.